📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: TxCell

1.1 - Company Overview

TxCell Logo

TxCell

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cell-based immuno-therapies for severe chronic inflammatory diseases with high medical need, using unique proprietary technology; a spin-off of Inserm based in Sophia Antipolis near Nice, France.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to TxCell

Philogen Logo

Philogen

HQ: Italy Website
  • Description: Provider of biopharmaceuticals targeting angiogenesis and tumor-associated blood vessels for the treatment of cancer and other serious conditions, with a pipeline including Nidlegy (clinical-stage), Fibromun (in clinical development), Darleukin for selective delivery to tumor sites, Dekavil and Dodekin targeting vascular antigens, and Onco IX utilizing vascular targeting.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Philogen company profile →
Galapagos Logo

Galapagos

HQ: Belgium Website
  • Description: Provider of small molecule medicines and investigational therapies in immunology and oncology. Develops CAR-T cell therapies via a decentralized manufacturing network and advances GLPG5101 (Phase 1/2 for relapsed/refractory non-Hodgkin lymphoma). Conducts clinical trials to evaluate treatments and seek regulatory approval; Jyseleca (filgotinib) transferred to Alfasigma.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Galapagos company profile →
Gesynta Pharma Logo

Gesynta Pharma

HQ: Sweden Website
  • Description: Provider of clinical-stage pharmaceutical R&D developing mPGES-1–inhibiting drug candidates to reduce inflammation and pain. Pipeline includes vipoglanstat (GS-248), a non-hormonal treatment for endometriosis in phase II, and GS-073 for chronic inflammatory pain entering phase I. Research originates from Karolinska Institutet; GS-073 from AstraZeneca.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Gesynta Pharma company profile →
Forward Pharma Logo

Forward Pharma

HQ: Denmark Website
  • Description: Provider of biotechnology focused on the immunomodulatory compound dimethyl fumarate and derivatives for pharmaceutical drug applications to treat immune disorders such as multiple sclerosis and psoriasis; founded in 2005 and headquartered in Copenhagen, Denmark.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Forward Pharma company profile →
Protalex Logo

Protalex

HQ: United States Website
  • Description: Provider of a class of biopharmaceutical drugs designed to treat autoimmune and inflammatory; a development stage company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Protalex company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for TxCell

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to TxCell

2.2 - Growth funds investing in similar companies to TxCell

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for TxCell

4.2 - Public trading comparable groups for TxCell

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to TxCell

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About TxCell

What does TxCell do?

TxCell is a provider of cell-based immuno-therapies for severe chronic inflammatory diseases with high medical need, using unique proprietary technology; a spin-off of Inserm based in Sophia Antipolis near Nice, France.

Who are TxCell's competitors?

TxCell's competitors and similar companies include Philogen, Galapagos, Gesynta Pharma, Forward Pharma, and Protalex.

Where is TxCell headquartered?

TxCell is headquartered in France.

How many employees does TxCell have?

TxCell has 1,000 employees 🔒.

When was TxCell founded?

TxCell was founded in 2010 🔒.

What sector and industry vertical is TxCell in?

TxCell is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for TxCell

Who are the top strategic acquirers in TxCell's sector and industry

Top strategic M&A buyers and acquirers in TxCell's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for TxCell?

Top strategic M&A buyers groups and sectors for TxCell include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in TxCell's sector and industry vertical

Which are the top PE firms investing in TxCell's sector and industry vertical?

Top PE firms investing in TxCell's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in TxCell's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in TxCell's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in TxCell's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to TxCell include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in TxCell's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for TxCell?

The key public trading comparables and valuation benchmarks for TxCell include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for TxCell for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for TxCell with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in TxCell's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for TxCell with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in TxCell's' sector and industry vertical?

Access recent funding rounds and capital raises in TxCell's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for TxCell